Health
Recce Pharmaceuticals” R327 demonstrates positive efficacy against ‘flesh-eating” bacteria – Proactive Investors Australia
RECCE® 327 (R327) has been shown to reduce deadly flesh-eating bacterial count below limit of quantification within 24 hours,…
RECCE® 327 (R327) has been shown to reduce deadly flesh-eating bacterial count below limit of quantification within 24 hours, at varying concentrations.Recce Pharmaceuticals Ltd (ASX:RCE) (FSE:R9Q), a company developing new classes of synthetic anti-infectives,…
Continue Reading
-
Noosa News17 hours agoWhat instrument did Japan’s heavy-metal PM play? Take the Brisbane Times Quiz
-
Noosa News23 hours agoBasic cyber steps can block most attacks – Proctor
-
Noosa News21 hours agoCompetition watchdog approves Elders’ $475m acquisition of agribusiness rival Delta
-
Noosa News20 hours agoFamily ‘quite nasty’ to woman who married step-uncle before his alleged murder, court hears